Vaccines, Blood & Biologics
Residual Moisture Test - Wilate, December 10, 2007
Date: December 10, 2007
From: Alfred V. Del Grosso, Ph.D., HFM-406, DPQ, OVRR
Hsiaoling Wang, Ph.D., HFM-406, DPQ, OVRR
To: Timothy Lee, Ph.D., HFM-392, DH, OBRR
Through: Rajesh Gupta, Ph. D., HFM-407, PQLS, DPQ, OVRR
Subject: Residual Moisture Test for six (6) Lots of Coagulation Factor VIII/von
Willebrand Factor Complex (Human) from Octapharma/1646
STN 125251_0
Residual moisture was measured by CBER using a Karl Fischer coulometric titration with methanol extraction of the lyophilized samples. Octapharma’s results are by a ----(b)(4)------------ method described in this BLA submission that is standardized against a -----(b)(4)-------------------- procedure. Test results are as follows:
| Mfr. -(b)(4)- Results | CBER’s KF Results * | ||
|---|---|---|---|
| Lot# | Moisture (%) | Moisture (%) | Test Date |
| ----(b)(4)----- | 1.1 | 0.93 | 05Dec07 |
| ----(b)(4)----- | 1.1 | 0.83 | 05Dec07 |
| ----(b)(4)----- | 0.9 | 0.72 | 05Dec07 |
| ----(b)(4)----- | 0.9 | 1.0 | 05Dec07 |
| ----(b)(4)----- | 1.2 | 0.94 | 05Dec07 |
| ----(b)(4)----- | 1. | 0.97 | 05Dec07 |
Octapharma has proposed a limit for the residual moisture content of -(b)(4)- for this product. Test results obtained by both CBER and the manufacturer meet this specification.
* Moisture values of Lots ---------------------(b)(4)------------------------ are average of 3 samples; moisture values of Lots --------------------------(b)(4)------------------------ are average of 2 samples.
cc: N. Baylor
R. Gupta







